Preparation and in vitro anticancer activity of oxymatrine mixed micellar nanoparticles

Pharmazie

Volumn 66, Issue 7, 2011, Pages 506-510

  Jin, Nan ^a   Zhao, Yong Xing ^a   Deng, Shu Hua ^a   Sun, Qian ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE; OXYMATRINE; POLOXAMER; ALKALOID; ANTINEOPLASTIC AGENT; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; EXCIPIENT; MACROGOL DERIVATIVE; METHOXY POLY(ETHYLENE GLYCOL) POLY(LACTIDE); METHOXY POLY(ETHYLENE GLYCOL)-POLY(LACTIDE); POLYESTER; QUINOLIZINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG FORMULATION; DRUG RELEASE; EVAPORATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; CALIBRATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; HUMAN; KINETICS; MICELLE; REPRODUCIBILITY; SOLUBILITY; STANDARD; TUMOR CELL LINE;

ALKALOIDS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CALIBRATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMPOUNDING; EXCIPIENTS; HUMANS; INDICATORS AND REAGENTS; KINETICS; MICELLES; NANOPARTICLES; POLOXAMER; POLYESTERS; POLYETHYLENE GLYCOLS; QUINOLIZINES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SOLUBILITY;

EID: 80051925957     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2011.0356     Document Type: Article

References (20)

1. Agrawal SK, Sanabria-DeLong N, Coburn JM, Tew GN, Bhatia SR (2006) Novel drug release profiles from micellar solutions of PLA-PEO-PLA triblock copolymers. J Control Release 112: 64-71.
2. He L, Li JH (2010) The review of targeted drug delivery system. China Modern Medicine 17: 15-17.
3. Hu MH (2009) Investigation of preparation and pharmacokinetics for oxymatrine liposome. Chongqing, China, Chongqing University of Medical Sciences. Master thesis.
4. Jones MC, Gao H, Lerous JC (2008) Reverse polymeric micelles for pharmaceutical applications. J Control Release 132: 208-215.
5. Liu XH (2007) Basic research on biopharmaceutic and pharmacokinetic characteristics of oxymatrine. Shenyang, China, Shenyang Pharmaceutical University. PhD thesis.
6. Mu CF, Balakrishnan P, Cui FD, Yin YM, Lee YB, Choi HG, Yong CS, Chung SJ, Shim CK, Kim DD (2010) The effects of mixed MPEG-PLA/Pluronic(R) copolymer micelles on the bioavailability and multidrug resistance of docetaxel. Biomaterials 31: 2371-2379.
7. Nishiyama N, Kataoka K (2006) Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther 112: 630-648. (Pubitemid 44592613)
8. Oerlemans C, Bult W, Bos M, Storm G, Nijsen JFW, Hennink WE (2010) Polymeric micelles in anticancer therapy: targeting, imaging and triggered release. Pharm Res 27: 2569-2589.
9. Olivier JC (2005) Drug transport to brain with targeted nanoparticles. NeuroRx 2: 108-119.
10. Rapoport N (2007) Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery. Prog Polym Sci 32: 962-990.
11. Shen XD, Song GB, Yan RB, Yang Y (2005) Research progress of matrine and oxymatrine in the anti-tumor mechanism. J Chongqing Univ (Natural Science Edition) 28:126-129.
12. Torchilin V (2001) Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 73: 137-172.
13. Vachutinsky Y, Oba M, Miyata K, Hiki S, Kano MR, Nishiyama N, Koyama H, Miyazono K, Kataoka K (2011) Antiangiogenic gene therapy of experimental pancreatic tumor by sFlt-1 plasmid DNA carried by RGD-modified crosslinked polyplex micelles. J Control Release 149: 51-57.
14. Wang JP, Kozo T, Tsuneji N, Yoshie M (2003) Pharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid, oleic acid, vitamin E and cholesterol. Int J Pharm 251: 13-21.
15. Wang Y, Meng-Gen DL, Zheng WY (2003) Pharmaeokinetics of oxymatrine injection in healthy volunteers. Chin J Clin Pharmacol 19: 301-305.
16. Yue PF, Yuan HL, Li XY, Yang M, Zhu WF (2010) Process optimization, characterization and evaluation in vivo of oxymatrine-phospholipid complex. Int J Pharm 387: 139-146.
17. Zheng H, Chen G, Shi L, Lou Z, Chen F, Hu J (2009) Determination of oxymatrine and its metabolite matrine in rat blood and dermal microdialysates by high throughput liquid chromatography/tandem mass spectrometry. J Pharm Biomed Anal 49: 427-433.
18. Zheng JM (2000) Medical Polymer Materials. In: Zheng JM (ed.) Chinese Medicine Science and Technology Press, 2nd ed., Beijing, P. 216-218.
19. Zheng XL, Kan B, Gou ML, Fu SZ, Zhang J, Men K, Chen LJ, Luo F, Zhao YL, Zhao X (2010) Preparation of MPEG-PLA nanoparticle for honokiol delivery in vitro. Int J Pharm 386: 262-267.
20. Zhou J, Yang G, Jin S, Tao L, Yu J, Jiang Y (2010) Oxymatrinecarbenoxolone sodium inclusion compound induces antinociception and increases the expression of GABAA [alpha] 1 receptors in mice. Eur J Pharmacol 626: 244-249.